Search IconSearch
June 3, 2024/Neurosciences/Podcast

Shedding Light on Stiff Person Syndrome (Podcast)

Heightened awareness of this rare disorder may lead to better diagnosis and treatment progress

When the singer Celine Dion was diagnosed with stiff person syndrome in 2022, it brought unprecedented attention to the rare neuroimmunologic disorder. Stiff person syndrome, which is challenging to diagnose, is a spectrum of disorders that cause fluctuating muscle rigidity and painful spasms that can severely impact mobility.


Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“I often describe its diagnosis with a puzzle analogy,” says Justin Abbatemarco, MD, a neurologist in Cleveland Clinic’s Mellen Center for Multiple Sclerosis Treatment and Research. “Many different pieces help me put the puzzle together and rule out other disorders — everything from the patient’s demographics, symptoms, exam findings and then all the testing — blood, cerebrospinal fluid, electromyography. It can be a real challenge to put together all these different elements.”

In the latest episode of Cleveland Clinic’s Neuro Pathways podcast, Dr. Abbatemarco sheds light on stiff person syndrome. He delves into:

  • Its different phenotypes and clinical features
  • Neurological exam features and diagnostic tests to identify the syndrome
  • Treatment, including administration of intravenous immunoglobin
  • A multidisciplinary approach to help patients accomplish activities of daily living and improve their quality of life
  • The search for better biomarkers to diagnose the syndrome and targeted immunotherapies to treat it

Click the podcast player above to listen to the 26-minute episode now, or read on for a short edited excerpt. Check out more Neuro Pathways episodes at clevelandclinic.org/neuropodcast or wherever you get your podcasts.

This activity has been approved for AMA PRA Category 1 Credit™and ANCC contact hours. After listening to the podcast, you can claim your credit here.

Excerpt from the podcast

Podcast host Glen Stevens, DO, PhD: The different phenotypes you mentioned obviously make it more challenging to reach the correct diagnosis. Take us through the diagnostic process for a patient you suspect might have stiff person syndrome. How do they present? What’s the workup?


Dr. Abbatemarco: If we talk about spasms and pain, those are really common neurological concerns that many of us see, so how do we delve into this more to know when we should be thinking about this syndrome and testing for it?

Demographics can be a helpful start. About 70% to 80% of patients with this syndrome are women, and it’s most common in women around 30 to 40 years old. What’s maybe a bit more unique is that 30% to 50% of these patients will have non-neurologic autoimmune diseases. Type 1 diabetes is one of the most common, along with autoimmune thyroid disorders and vitiligo. So, the presence of other autoimmune diseases in that demographic group would at least raise my antenna that maybe I should be thinking about this syndrome.

When we talk about the symptoms we see in this disease, we hear about spasms and rigidity. To help break that down, though, be aware that the rigidity usually involves the trunk. It usually starts in the abdomen or low back. Sometimes the rigidity can involve both sides, and it can create a hyperlordosis along with a boardlike feeling all around the abs. Then it spreads into the extremities, and patients will usually have some rigidity in the lower extremities.

On top of that, patients will then experience spasms. Again, they often involve the trunk, and they can be triggered by loud sounds and sometimes by touch or by emotional triggers. The spasms can be extremely painful. That’s the clinical phenotype we typically see. It is a progressive disease, so it can start by involving one area and then spread to others over months to years.


Related Articles

September 27, 2022/Neurosciences/Pediatrics
Making Pediatrics More of a Priority in Multiple Sclerosis Treatment Trials

New review makes the case for earlier pediatric enrollment and other changes

Dr. Amy Kunchok against decorative background
July 16, 2024/Neurosciences/Podcast
What to Know About Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) (Podcast)

It’s time to get familiar with this emerging demyelinating disorder

receptor activity for myasthenia gravis medications
July 3, 2024/Neurosciences/Podcast
Myasthenia Gravis: Unmet Needs and Efforts to Address Them (Podcast)

An overview of associated antibodies, therapies for antibody-positive disease and the outlook for atypical forms of MG

adult female figure suffering headache
June 17, 2024/Neurosciences/Podcast
Migraine Relief: Providing Preventive and Abortive Therapies (Podcast)

A close look at the growing array of options for episodic and chronic migraine

pills, syringes and vials on a tabletop
May 15, 2024/Neurosciences/Podcast
Multiple Sclerosis Medications: Making the Most of a Multitude of Options (Podcast)

Insights on the decision process for selecting a treatment approach

doctor applying force to patient's forearm to test strength
Offering Rehabilitation Care to Oncology Patients (Podcast)

New oncologic rehab program is tailored to managing the effects of cancer and its treatments

syringe being prepared for injection
April 15, 2024/Neurosciences/Podcast
Balancing Benefits and Pitfalls of Neurotoxin Injections (Podcast)

Determining the right dose and injecting in the right muscle can be challenging

inflammation on a brain scan with a podcast button overlay
April 2, 2024/Neurosciences/Podcast
Diagnosis and Management of Cerebral Amyloid Angiopathy-Related Inflammation (Podcast)

New research sheds light on a potentially devastating condition that is reversible when properly managed